• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P-钙黏蛋白在非肌肉浸润性膀胱癌中的预后价值。

The prognostic value of P-cadherin in non-muscle-invasive bladder cancer.

机构信息

Department of Urology, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.

Department of Pathology, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Eur J Surg Oncol. 2014 Mar;40(3):255-9. doi: 10.1016/j.ejso.2013.12.018. Epub 2014 Jan 2.

DOI:10.1016/j.ejso.2013.12.018
PMID:24429027
Abstract

OBJECTIVES

This research aims to specify the prognostic value of P-cadherin on recurrence and progression in non-muscle-invasive bladder cancers (NMIBC).

METHODS

A total of 110 NMIBC cases were collected and P-cadherin protein was assessed by immunohistochemical test in these samples. Correlations between P-cadherin expression and clinicopathologic features were analyzed. For recurrence-free and progression-free survival, Kaplan-Meier log-rank test was used. Then Cox univariate and multivariate analyses were further performed.

RESULTS

P-cadherin high expression correlated with tumor progression (P = 0.031). Kaplan-Meier results showed that patients with high P-cadherin expression had worse progression-free survival (P = 0.034) but not recurrence-free survival (P = 0.133) than low-expression patients. Cox regression results showed P-cadherin expression was an independent predictor for progression (P = 0.042) but not recurrence (P = 0.139) in NMIBC.

CONCLUSIONS

Our results demonstrated that P-cadherin expression correlated with tumor progression and could be taken as an independent predictor for progression in NMIBC.

摘要

目的

本研究旨在明确 P-钙黏蛋白(P-cadherin)在非肌层浸润性膀胱癌(NMIBC)复发和进展中的预后价值。

方法

收集了 110 例 NMIBC 病例,并通过免疫组织化学试验对这些样本中的 P-cadherin 蛋白进行评估。分析 P-cadherin 表达与临床病理特征之间的相关性。采用 Kaplan-Meier 对数秩检验分析无复发生存期和无进展生存期,然后进行 Cox 单因素和多因素分析。

结果

P-cadherin 高表达与肿瘤进展相关(P=0.031)。Kaplan-Meier 结果显示,P-cadherin 高表达患者的无进展生存期(P=0.034)较低表达患者差,但无复发生存期(P=0.133)无差异。Cox 回归结果显示,P-cadherin 表达是 NMIBC 进展的独立预测因子(P=0.042),但不是复发的独立预测因子(P=0.139)。

结论

我们的结果表明,P-cadherin 表达与肿瘤进展相关,可作为 NMIBC 进展的独立预测因子。

相似文献

1
The prognostic value of P-cadherin in non-muscle-invasive bladder cancer.P-钙黏蛋白在非肌肉浸润性膀胱癌中的预后价值。
Eur J Surg Oncol. 2014 Mar;40(3):255-9. doi: 10.1016/j.ejso.2013.12.018. Epub 2014 Jan 2.
2
Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.原发性非肌肉浸润性膀胱癌拓扑异构酶-IIα表达的临床意义及预后价值。
Urology. 2010 Jun;75(6):1516.e9-13. doi: 10.1016/j.urology.2009.08.055. Epub 2009 Nov 13.
3
Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.Ras 相关结构域家族 1A:复发性非肌肉浸润性膀胱癌有前途的预后标志物。
Clin Genitourin Cancer. 2012 Jun;10(2):114-20. doi: 10.1016/j.clgc.2011.12.003. Epub 2012 Feb 28.
4
HMOX1 is an important prognostic indicator of nonmuscle invasive bladder cancer recurrence and progression.HMOX1 是预测非肌肉浸润性膀胱癌复发和进展的一个重要预后指标。
J Urol. 2011 Feb;185(2):701-5. doi: 10.1016/j.juro.2010.09.081. Epub 2010 Dec 18.
5
PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer.PFKFB4 作为非肌肉浸润性膀胱癌的预后标志物。
Urol Oncol. 2012 Nov-Dec;30(6):893-9. doi: 10.1016/j.urolonc.2010.08.018. Epub 2011 Mar 10.
6
Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?fascin-1的表达及肿瘤亚分类是否有助于评估T1期膀胱尿路上皮癌的复发和进展风险?
Urol Int. 2008;80(4):413-8. doi: 10.1159/000132700. Epub 2008 Jun 27.
7
RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.RUNX3 甲基化作为非肌肉浸润性膀胱癌患者疾病进展的预测因子。
J Surg Oncol. 2012 Mar 15;105(4):425-30. doi: 10.1002/jso.22087. Epub 2011 Aug 30.
8
Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.Ki-67是非肌肉浸润性膀胱癌(NMIBC)的一个独立指标;欧洲癌症研究与治疗组织(EORTC)风险评分与Ki-67表达相结合可改善NMIBC的风险分层。
Urol Oncol. 2014 Jan;32(1):42.e13-9. doi: 10.1016/j.urolonc.2013.05.004.
9
Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.CK20 和 Ki-67 免疫组化联合分析预测 pT1 尿路上皮膀胱癌的复发、进展和癌症特异性生存。
Eur Urol. 2014 Jan;65(1):218-26. doi: 10.1016/j.eururo.2012.05.033. Epub 2012 May 19.
10
Overexpression of RING box protein-1 (RBX1) associated with poor prognosis of non-muscle-invasive bladder transitional cell carcinoma.RING 盒蛋白-1(RBX1)过表达与非肌肉浸润性膀胱移行细胞癌不良预后相关。
J Surg Oncol. 2013 Jun;107(7):758-61. doi: 10.1002/jso.23317. Epub 2013 Apr 23.

引用本文的文献

1
PCDH9 suppresses melanoma proliferation and cell migration.原钙黏蛋白9抑制黑色素瘤的增殖和细胞迁移。
Front Oncol. 2022 Nov 14;12:903554. doi: 10.3389/fonc.2022.903554. eCollection 2022.
2
Non-muscle invasive bladder cancer biomarkers beyond morphology.超越形态学的非肌层浸润性膀胱癌生物标志物
Front Oncol. 2022 Aug 3;12:947446. doi: 10.3389/fonc.2022.947446. eCollection 2022.
3
Proteomics as a Complementary Technique to Characterize Bladder Cancer.蛋白质组学作为一种用于表征膀胱癌的补充技术。
Cancers (Basel). 2021 Nov 4;13(21):5537. doi: 10.3390/cancers13215537.
4
Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma.CDK7 通过转录调控 DNA 修复网络,调节 MYC 驱动的髓母细胞瘤对辐射的敏感性。
Cell Rep. 2021 Apr 27;35(4):109013. doi: 10.1016/j.celrep.2021.109013.
5
Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples.Ephrin-B1是膀胱癌侵袭性的一种新型生物标志物。在小鼠模型和人类样本中的研究。
Front Oncol. 2020 Mar 27;10:283. doi: 10.3389/fonc.2020.00283. eCollection 2020.
6
Low Frequency of Intratumor Heterogeneity in Bladder Cancer Tissue Microarrays.膀胱癌组织微阵列中肿瘤内异质性的低频率
Bladder Cancer. 2018 Jul 30;4(3):327-337. doi: 10.3233/BLC-180176.
7
Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression.重新评估上皮-间充质转化在癌症进展中的作用。
J Biomed Res. 2018 Mar 26;32(2):81-90. doi: 10.7555/JBR.31.20160124.
8
P-cadherin and the journey to cancer metastasis.P-钙黏蛋白与癌症转移之旅
Mol Cancer. 2015 Oct 6;14:178. doi: 10.1186/s12943-015-0448-4.
9
The promise of novel molecular markers in bladder cancer.膀胱癌中新型分子标志物的前景。
Int J Mol Sci. 2014 Dec 22;15(12):23897-908. doi: 10.3390/ijms151223897.
10
Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena.细胞黏附与膀胱尿路上皮癌:钙黏蛋白转换及相关现象的作用
Philos Trans R Soc Lond B Biol Sci. 2015 Feb 5;370(1661):20140042. doi: 10.1098/rstb.2014.0042.